Form 4: Zimmer Biomet Exec VP Suketu Upadhyay Reports Stock Transactions

Executive VP and CFO of Zimmer Biomet Holdings, Suketu Upadhyay, reports the vesting of restricted stock units and subsequent tax withholding.

Summary

• Suketu Upadhyay, Executive VP and CFO of Zimmer Biomet Holdings, Inc., filed a Form 4 on February 24, 2025.
• The report details transactions related to restricted stock units (RSUs).
• On February 20, 2025, 5,446 RSUs vested and were converted into common stock.
• A portion of the shares (2,423) were withheld by the company to cover tax obligations at a price of $103.46 per share.
• Following these transactions, Upadhyay directly owns 46,322 shares of Zimmer Biomet common stock and 10,890 restricted stock units.
• One-third of the RSUs vested on February 20, 2025, with the remainder vesting in two equal installments on February 20, 2026, and February 20, 2027.

Sentiment

Score: 5

Explanation: The document is a standard regulatory filing detailing stock transactions, with no inherent positive or negative sentiment.

Future Outlook

The remaining RSUs will vest in two equal installments on February 20, 2026, and February 20, 2027.

Industry Context

This filing is a routine disclosure related to executive compensation and stock ownership, common in publicly traded companies like Zimmer Biomet. It provides transparency into the financial interests of key executives.

Stakeholder Impact

• The filing provides transparency to shareholders regarding executive compensation and stock ownership.

Key Dates

Keywords

Form 4, Zimmer Biomet, Suketu Upadhyay, Executive VP, CFO, Stock, RSU, Restricted Stock Units, Vesting, Tax Withholding